Literature DB >> 11159790

Detection of MboII polymorphism at the 5' promoter region of CYP3A4.

S A Cavalli1, M H Hirata, R D Hirata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159790

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  12 in total

1.  CYP3A phenotypes and genotypes in North Indians.

Authors:  Naushad Rais; Yogesh K Chawla; Krishan K Kohli
Journal:  Eur J Clin Pharmacol       Date:  2006-04-21       Impact factor: 2.953

2.  Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.

Authors:  Fabiana B Kohlrausch; Ángel Carracedo; Mara H Hutz
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

3.  The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot study.

Authors:  Guillermo Gervasini; Sonia Vizcaino; Juan Antonio Carrillo; Maria Jesus Caballero; Julio Benitez
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

4.  Effect of gene polymorphisms on the levels of calcineurin inhibitors in Indian renal transplant recipients.

Authors:  T Ashavaid; H Raje; K Shalia; B Shah
Journal:  Indian J Nephrol       Date:  2010-07

5.  ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients.

Authors:  Montserrat García; Rosa María Macías; Juan José Cubero; Julio Benítez; Francisco Caravaca; Guillermo Gervasini
Journal:  Eur J Clin Pharmacol       Date:  2012-08-11       Impact factor: 2.953

6.  The ABCB1 3435 T allele does not increase the risk of paclitaxel-induced neurotoxicity.

Authors:  Anna Ofverholm; Zakaria Einbeigi; Shokoufeh Manouchehrpour; Per Albertsson; Stanko Skrtic; Charlotta Enerbäck
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

7.  Genotype and Allele Frequency of CYP3A4 -392A>G in Turkish Patients with Major Depressive Disorder.

Authors:  Zuhal Uçkun; Bora Baskak; Hatice Özdemir; Erguvan Tuğba Özel-Kizil; Halise Devrimci-Özgüven; Halit Sinan Süzen
Journal:  Turk J Pharm Sci       Date:  2018-07-17

8.  Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.

Authors:  Angela Roco; Luis Quiñones; José A G Agúndez; Elena García-Martín; Valentina Squicciarini; Carla Miranda; Joselyn Garay; Nancy Farfán; Iván Saavedra; Dante Cáceres; Carol Ibarra; Nelson Varela
Journal:  Front Genet       Date:  2012-11-02       Impact factor: 4.599

9.  Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.

Authors:  Guillermo Gervasini; Elena García-Martín; José M Ladero; Rosa Pizarro; Javier Sastre; Carmen Martínez; Monserrat García; Manuel Diaz-Rubio; José A G Agúndez
Journal:  BMC Cancer       Date:  2007-07-02       Impact factor: 4.430

10.  Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.

Authors:  C Martínez; E García-Martín; R M Pizarro; F J García-Gamito; J A G Agúndez
Journal:  Br J Cancer       Date:  2002-09-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.